Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 31 - 40 out of 46

AMIA Comments on FDA Mobile Medical Apps Draft Guidance

October 19, 2011

AMIA recently issued comments in response to a U.S. Food and Drug Administration (FDA) draft guidance on mobile medical applications. In the comments, AMIA president Ted Shortliffe noted, among other things, the need for additional clarification, definitions, terms, and terminology in the guidance. Click below to read AMIA's full comments.

AMIA Identifies Areas to Strengthen Federal Health IT Strategic Plan

May 6, 2011

AMIA has weighed in on the Federal Health IT Strategic Plan in response to the HHS Office of the National Coordinator’s (ONC) call for comments on the overarching strategy for realizing health IT goals set forth by the U.S. Congress and the Administration. AMIA states in its comments to ONC […]

AMIA Board Position on Ethics: Vendor Values, Patient Safety and Best Practices

November 12, 2010

The current commercial health information technology (IT) arena encompasses a number of competing firms that provide electronic health applications to hospitals, clinical practices, and other healthcare-related entities. Such applications collect, store, and analyze patient information. Some vendors incorporate contract language whereby purchasers of health IT systems, such as hospitals and […]

AMIA Submits Comments to DEA on E-Prescribing Controlled Substances

May 29, 2010

AMIA comments to DEA on E-Prescribing Controlled Substances which would revise the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Controlled Substances Act, or CSA) and the related regulations to allow healthcare providers to write prescriptions for controlled substances electronically. These revisions would have to allow e-prescribing controlled substances […]

AMIA Testimony to HIT Policy Committee on Patient Safety and HIT

February 25, 2010

AMIA’s testimony to the HIT Policy Committee, Adoption/Certification Workgroup, discusses potential unintended consequences of health information technology (HIT) and HIT policy, as well as effective options for addressing them. AMIA and its task force offer several recommendations that involve unintended consequences and conjure questions from previous observations in identifying safety […]